1 / 15

Hepatitis:

Hepatitis:. Hepatitis is the inflammation of liver caused by immune response against : liver parenchyma induced by viral infections , or some intracellular pathogens that survive in Kupffer cells causing granulomatous infections (Typhoid fever, brucellosis, Q fever, T.B).

waite
Download Presentation

Hepatitis:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hepatitis: Hepatitis is the inflammation of liver caused by immune response against : liver parenchyma induced by viral infections, or some intracellular pathogens that survive in Kupffer cells causing granulomatous infections (Typhoid fever, brucellosis, Q fever, T.B). Liver abscesses: 1-Portal Vein Bacteremia. 2-Hepatic Artery Systemic Bacteremia. 3-Ascending Cholangitis.

  2. N Viral causative agents for hepatitis are: 1- Professional-hepatitis viruses: Hepatitis A,B,C,D, and E; strong tropism to hepatocyte. 2-Non-Professional viruses that cause extra-hepatic diseases: Yellow fever viruses, E.B virus secondary to I.M, CMV, adenovirus, Herpes simplex, and VZV.

  3. Hepatitis Viruses: Hepatitis A, B, C, D, and E: N

  4. Hepatitis B virus: Pathogenesis: -Infection of hepatocytes. -T-cell mediated cytotoxicity: interaction between hepatocyte-MHC classI-HBcAg or HBeAgfragments and CD8+-TCR. -Kupffer cell response; release of cytokines and inflammatory mediators; chemotaxis. -Enhanced natural killer cell activity; cytotoxicity. -Interferon-α production; Up-regulates MHC-I expression and inhibits viral replication cycle. -HBsAg/Anti-HBsAg Antibodies complexes activate complement system damage.

  5. Clinical presentation of Hepatitis B infection: -Incubation period. -Acute infection period: A-Pre-Ictericphase: (days to week): mild fever, anorexia, myalgia, and nausea. B-Icteric acute phase: (one to two months): Jaundice(yellowish coloration of mucous membrane, conjunctivae, and skin), enlarged and tender liver. C-Fulminanthepatitis: (In 1-2% of patients): Much more extensive necrosis of liver during icteric phase; elevated fever, abdominal pain, renal dysfunction, Lethal in 8% of cases.

  6. Acute Hepatitis B infection n Virulent strain of hepatitis, Co-infection (HDV), Uncontrolled immunity and cytokines Limited cell-mediated and humoral immunity Effective cell-mediated and humoral immunity Chronic stage; Asymptomatic carrier N Chronic active hepatitis Resolution Minimal chronic hepatitis (persistent) Fulminant Hepatitis Liver Cirrhosis Hepatocellular Carcinoma

  7. Diagnosis of Hepatitis B infection: -In incubation period and pre-icteric phase: The first indicator is HBsAg and HBeAg(envelope). -In acute icteric phase: Elevated Bilirubin(T,D), Liver enzymes (Transaminases), Bilirubinuria , elevated Anti-HBc Antibodies in serum. -In Convalescence phase: Anti-HBs Antibodies starts elevation in serum(positive). -In Chronic period: HBs Ag: positive Anti-HBc Antibodies: positive Anti-HBs Antibodies: negative.

  8. Diagnosis of Hepatitis B infection: Ni

  9. Treatment and Prevention: -Reduction or elimination of HBV replication indicators could be performed by Interferon-alpha therapy. -Antiviral-nucleoside analogs that given orally have similar effect on viral replication (Lamivudine oradefovir: inhibition of viral reverse transcriptase). Prevention: 1-Active vaccine:HBsAg (children vaccination or others). 2-Passive vaccine: Serum Anti-HBsAg (exposed persons; needlestick , infants born to seropositive mother, sexual)

  10. Hepatitis C virus infection: HCV accounted for ninety percent of cases of non-A, non-B hepatitis. Transmission: 1-It was initially identified as a major cause of post- transfusion hepatitis. 2-Intravenous drug users 3-Patients on hemodialysis. 4-Sexual route, and vertical. Pathogenesis: -Replication of virus in hepatocytes, lymphocytes, and macrophages. -Destruction of cells by viral replication cycle and immunity.

  11. Acute hepatitis C infection Clinical outcomes of acute hepatitis C infection: Subclinical infection in 75% of cases Acute hepatitis C (25% of cases) Resolution of disease (months) Chronic hepatitis C (10-15 years) N Mixed Cryoglobulinemia Cirrhosis (20%) Hepatocellular Carcinoma Liver failure

  12. N Diagnosis of HCV: -Detection of Anti-HCV-Recombinant viral protein antibodies in patient serum by ELISA. -Detection of viral nucleic acid in serum by RT-PCR technique. Treatment and Prevention: -Combination therapy of interferon-αand ribavirin provides a significantly improved response ( 30-50% for genotype 1 and 70-75% for viral genotype 2 and 3). -No available vaccine.

  13. Hepatitis A infection: -HAV is responsible for most cases of infectious hepatitis. -Non-enveloped SS-RNA Virus. -Transmission: Fecal-Oral route or contaminated water. -Pathogenesis: -Absorbed into bloodstream by intestine; portal system of liver. -Replication in hepatocytes; destruction, exported into bile ducts; excreted into stool ( a high titer=1011viron/ml) -Released in bloodstream (to a lesser extent); transient viremia. -Acute hepatitis; inactivated vaccine (cell-cultured). Post-exposure prophylaxis (Anti-HAV-Abs).

  14. Other causative agents for liver infection: Bacterial infections: Liver abscesses formation. 1-Portal-vein bacteremia. 2-Hepatic artery bacteremia. 3-Ascending cholangitis; E.coliis the most frequent agent 40% Facultative anaerobic and obligate anaerobic ascends from the duodenum. Several Parasitic infections: 1-Leishmaniasis: Leishmania donovani ; Visceral leishmaniasis (Kala-azar); jaundice, A/G ratio. In liver: intracellular Amastigotestage.

  15. N 2-Extra-intestinal Amebiasis: Entamoebahistolytica Causes hepatic cyst due to transfer of trophozoite via portal system. 3-Schistosomiasis: Schistosoma mansoni; Schistosomula migrates to venous system of liver then to venous plexuses of large intestine. In liver: Egg-Granulomas in portal area. Pipe stem fibrosis of portal tracts. 4-Malarialife cycle: Plasmodium causes liver Schizonts.

More Related